ReviewWorld journal of gastrointestinal endoscopy2025
Peroral endoscopic myotomy in children with achalasia: A review of the literature.
Review in World journal of gastrointestinal endoscopy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Achalasia is a rare esophageal motility disorder characterized by the inability of the lower esophageal sphincter (LES) to relax, accompanied by the loss of peristalsis in the esophageal body. Although more prevalent in adults, pediatric achalasia poses unique diagnostic challenges due to its atypical presentation. Peroral Endoscopic Myotomy (POEM) has emerged as a minimally invasive alternative to laparoscopic Heller myotomy for managing achalasia, particularly in children, but its efficacy and safety remain under-investigated. A comprehensive literature review was conducted to assess the role of POEM in pediatric achalasia, focusing on procedure efficacy, clinical outcomes, and safety. Key parameters included pre- and post-procedure Eckardt scores and adverse events. Comparison of outcomes with alternative interventions, such as laparoscopic myotomy and pneumatic dilation were also investigated. Currently, POEM achieves high clinical success in pediatric patients, with significant reduction in post-procedure Eckardt scores and LES pressures. Clinical success rates of up to 90% with durable symptom relief have been observed over follow-up exceeding one year. Common adverse events include mucosal injury, capnoperitoneum, and postoperative reflux. This comprehensive review reveals that POEM is as effective as laparoscopic myotomy but offers shorter hospital stay and reduced recovery time at the cost of a higher complication rate. POEM is an effective treatment for pediatric achalasia, providing durable symptom relief, comparable to traditional interventions. Future research should focus on the identification of pediatric patients that would benefit the most from POEM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.